(Corrects paragraph 15 to reflect that Hims & Hers is one of the most volume-producing of Novo’s partners, and not the most ...
Hims & Hers Health could see a growth surge as employers drop coverage for weight-loss drugs due to soaring costs. Consumers ...
Shares of Hims & Hers Health (HIMS) slipped 2% in overnight trading late Sunday after the company's chief medical officer ...
Barclays expects accelerating revenue and EBITDA growth in the second half of 2026, supported by weight-loss offerings.
Indian American specialist to guide wellness platform’s expansion of its preventive care and longevity offerings for men.
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2024 ...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2026 financial results ...
After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) is now expanding its offerings to include at-home blood tests. The company ...
Hims is rolling out a new Weight Loss Membership that lets you get started for $39 for the first month. You’ll get 24/7 messaging with licensed providers, a dedicated Care Team, ...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform committed to breaking down barriers to safe and affordable healthcare, ...
By Amina Niasse NEW YORK, June 25 (Reuters) - Telehealth provider Hims and Hers Health may get a boost next year from ...
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2025 financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results